Estudo randomizado | Vacinação em dose única contra o HPV se mostrou efetiva entre mulheres jovens na África.
14 Abr, 2022 | 17:07hEfficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women – NEJM Evidence
Comunicado de imprensa:
Study boosts support for single-dose HPV vaccine regimen – University of Washington
Conteúdo relacionado: Three-year follow-up of 2-dose versus 3-dose HPV vaccine
Comentário no Twitter (fio – clique para saber mais)
🚨 GAME CHANGER 🚨
One-dose Human Papillomavirus (#HPV) vaccine offers solid protection against cervical cancer: WHO https://t.co/3uWlZlCCVK pic.twitter.com/ZKDvpf2qog— World Health Organization (WHO) (@WHO) April 11, 2022


